Literature DB >> 17927217

Restoration of enzymatic activity in a Ser-49 phospholipase A2 homologue decreases its Ca(2+)-independent membrane-damaging activity and increases its toxicity.

Toni Petan1, Igor Krizaj, Joze Pungercar.   

Abstract

Ammodytin L (AtnL) is a Ser-49 secretory phospholipase A2 (sPLA2) homologue with myotoxic activity. By analogy to the Lys-49 sPLA2 myotoxins, AtnL has been predicted to be enzymatically inactive due to the absence of the conserved Asp-49 that participates in coordination of the Ca2+ cofactor. By substituting Ser-49 and three other residues in the Ca2+-binding loop of AtnL, we obtained the first two enzymatically active mutants of Lys-49/Ser-49 sPLA2 homologues. The mutants LW and LV, which differed only by the presence of Trp and Val at position 31, respectively, efficiently hydrolyzed phospholipid vesicles, while recombinant AtnL displayed no activity. In contrast to AtnL but similarly to ammodytoxin A (AtxA), a homologous neurotoxic sPLA2, both mutants exhibited catalysis-dependent membrane-damaging ability, involving vesicle contents leakage and fusion. However, LW and LV also exhibited the potent, Ca2+-independent disruption of vesicle integrity characteristic of AtnL, but not of AtxA, in which leakage of the contents is not associated with membrane fusion. Although LV and, especially, LW have the advantage over AtnL of being able to act in both Ca2+-independent and Ca2+-dependent modes, and display higher cytotoxicity and higher lethal potency, they have a lower Ca2+-independent membrane-damaging potency and display reduced specificity in targeting muscle fibers in vitro. Our results indicate that, in evolution, Lys-49 and Ser-49 sPLA2 myotoxins have lost their Ca2+-binding ability and enzymatic activity through subtle changes in the Ca2+-binding network without affecting the rest of the catalytic machinery, thereby optimizing their Ca2+-independent membrane-damaging ability and myotoxic activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17927217     DOI: 10.1021/bi701304e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Role of enzymatic activity in muscle damage and cytotoxicity induced by Bothrops asper Asp49 phospholipase A2 myotoxins: are there additional effector mechanisms involved?

Authors:  Diana Mora-Obando; Cecilia Díaz; Yamileth Angulo; José María Gutiérrez; Bruno Lomonte
Journal:  PeerJ       Date:  2014-09-16       Impact factor: 2.984

2.  Synergism between basic Asp49 and Lys49 phospholipase A2 myotoxins of viperid snake venom in vitro and in vivo.

Authors:  Diana Mora-Obando; Julián Fernández; Cesare Montecucco; José María Gutiérrez; Bruno Lomonte
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

Review 3.  Snake Venom PLA2, a Promising Target for Broad-Spectrum Antivenom Drug Development.

Authors:  Huixiang Xiao; Hong Pan; Keren Liao; Mengxue Yang; Chunhong Huang
Journal:  Biomed Res Int       Date:  2017-11-29       Impact factor: 3.411

4.  Comparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcripts.

Authors:  Nicholas R Casewell; Robert A Harrison; Wolfgang Wüster; Simon C Wagstaff
Journal:  BMC Genomics       Date:  2009-11-30       Impact factor: 3.969

5.  A neurotoxic phospholipase A2 impairs yeast amphiphysin activity and reduces endocytosis.

Authors:  Mojca Mattiazzi; Yidi Sun; Heimo Wolinski; Andrej Bavdek; Toni Petan; Gregor Anderluh; Sepp D Kohlwein; David G Drubin; Igor Križaj; Uroš Petrovič
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

6.  Chemical modifications of PhTX-I myotoxin from Porthidium hyoprora snake venom: effects on structural, enzymatic, and pharmacological properties.

Authors:  Salomón Huancahuire-Vega; Daniel H A Corrêa; Luciana M Hollanda; Marcelo Lancellotti; Carlos H I Ramos; Luis Alberto Ponce-Soto; Sergio Marangoni
Journal:  Biomed Res Int       Date:  2012-12-19       Impact factor: 3.411

7.  Neurotoxic phospholipase A2 toxicity model: An insight from mammalian cells.

Authors:  Nina Vardjan; Mojca Mattiazzi; Edward G Rowan; Igor Križaj; Uroš Petrovič; Toni Petan
Journal:  Commun Integr Biol       Date:  2013-04-09

8.  Snake Venom Cytotoxins, Phospholipase A2s, and Zn2+-dependent Metalloproteinases: Mechanisms of Action and Pharmacological Relevance.

Authors:  Sardar E Gasanov; Ruben K Dagda; Eppie D Rael
Journal:  J Clin Toxicol       Date:  2014-01-25

9.  Identification of Lys49-PLA2 from crude venom of Crotalus atrox as a human neutrophil-calcium modulating protein.

Authors:  Md Tipu Sultan; Hong-Mei Li; Yong Zu Lee; Soon Sung Lim; Dong-Keun Song
Journal:  Korean J Physiol Pharmacol       Date:  2016-02-23       Impact factor: 2.016

Review 10.  Cytotoxicity of snake venom enzymatic toxins: phospholipase A2 and l-amino acid oxidase.

Authors:  Jia Jin Hiu; Michelle Khai Khun Yap
Journal:  Biochem Soc Trans       Date:  2020-04-29       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.